Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers
This study has been completed.
Sponsor:
Tau Therapeutics LLC
Collaborators:
Celerion, Inc.
Dana-Farber/Partners CancerCare, Inc.
LifeWatch, Inc.
Information provided by (Responsible Party):
Tau Therapeutics LLC
ClinicalTrials.gov Identifier:
NCT01550458
First received: February 29, 2012
Last updated: July 11, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2012 |
| Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |